Patient Square Capital LP
Annual return '25
+15.8%
SPY '25
+17.7%
Alpha
-1.9ptsvs SPY
Invested
$563.6M
Holdings
29
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 81%. 4 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$ROIV
ROIVANT SCIENCES LTD
Held since at least Q1 2024
40.1%
02
$ARGX
ARGENX SE
Held since at least Q1 2024
4.8%
03
$INSM
INSMED INC
Held since at least Q1 2024
4.6%
04
$ONC
BEONE MEDICINES LTD
Held since at least Q1 2024
4.2%
05
$COGT
COGENT BIOSCIENCES INC
Held since at least Q1 2024
4.1%
06
$MIRM
MIRUM PHARMACEUTICALS INC
Held since at least Q1 2024
3.8%
07
$BLTE
BELITE BIO INC
Held since at least Q1 2024
3.3%
08
$LEGN
LEGEND BIOTECH CORP
Held since at least Q1 2024
3.2%
09
$NKTR
NEKTAR THERAPEUTICS
Held since at least Q1 2024
2.7%
10
$DBVT
DBV TECHNOLOGIES S A
Held since at least Q1 2024
2.6%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 08:29 UTC.